Section 1 Glaucoma in the World 1. Prevalence and Geographic Variations 2. Screening for Glaucoma Section 2 Pathogenesis 3. Aqueous Humor Dynamics and Intraocular Pressure Elevation 4. Pathogenesis of Glaucomatous Optic Neuropathy 5. Mechanical Strain and Restructuring of the Optic Nerve Head 6. Role of Vascular Blood Flow in the Pathogenesis of Glaucoma 7. Metabolism, Ageing, and Glaucoma Pathogenesis Section 3 Evaluation of Glaucoma 8.
Tonometry and Intraocular Pressure Fluctuation 9. Visual Fields 10. Long Term Follow-Up of Visual Fields 11. Function-Specific Perimetry 12. New Approaches to Perimetry 13. Electrophysiology in Glaucoma Assessment 14. Gonioscopy 15. Ultrasound Biomicroscopy and Angle Imaging 16.
Angle Imaging: Anterior Segment Optical Coherence Tomography 17. Corneal Biomechanics in Glaucoma 18. Optic Disc Photography in Diagnosis of Glaucoma 19. Optic Disc Imaging 20. Retinal Nerve Fiber Layer Analysis 21. Optical Coherence Tomography Angiography in Glaucoma Diagnosis (OCTA) 22. Measuring Glaucoma Progression in Clinical Practice 23. Genetics of Glaucoma 24.
Genetic Epidemiology Section 4 Types of Glaucoma 25. Ocular Hypertension 26. Primary Open-Angle Glaucoma 27. Normal Tension Glaucoma 28. Exfoliation Syndrome and Exfoliative Glaucoma 29. Pigmentary Glaucoma 30. Primary Angle-Closure Glaucoma 31. Secondary Angle-Closure Glaucoma 32.
Neovascular Glaucoma 33. Uveitic Glaucoma 34. Glaucoma Secondary to Trauma 35. Glaucoma and Intraocular Tumors 36. Glaucoma in the Phakomatoses and Related Conditions 37. Other Secondary Glaucomas 38. Childhood Glaucomas Section 5 Principles of Management 39. Management of Ocular Hypertension and Primary Open-angle Glaucoma 40.
An Overview of Angle-Closure Management 41. Quality of Life 42. Optimizing Patient Outcomes in Glaucoma: Effectiveness of Glaucoma Treatments on Quality of Life 43. Ocular Hypotensive Medications: Adherence and Performance 44. Outcomes - Goals of Treatment 45. Benefit Versus Risk Section 6 Medical Therapy 46. Prostagladin Analogues 47. Beta-blockers 48.
Carbonic Anhydrase Inhibitors 49. Alpha Agonists 50. Rhokinase 51. Parasympathomimetics 52. Fixed Combination Therapies in Glaucoma 53. Ocular Surface Disease and the Role of Preservatives in Glaucoma Medications 54. Sustained delivery systems for Glaucoma Medications 55. Marijuana and Glaucoma 56.
Management of Acute Intraocular Pressure Rise Section 7 Surgery: Introduction 57. Laser as First Line Treatment 58. Surgery as First Line Treatment 59. The Trabecular Meshwork Outflow Pathways: Surgical Aspects Section 8 Laser Therapy 60. Selective Laser Trabeculoplasty 61. Peripheral Iridotomy for Angle-Closure Glaucoma 62. Laser Peripheral Iridoplasty Section 9 Trabeculectomy 63. Ophthalmic Anesthesia 64.
Trabeculectomy: Preoperative Evaluation and Management 65. Trabeculectomy 66. Wound Healing and Bleb Evaluation after Trabeculectomy 67. Intraoperative Complications of Trabeculectomy 68. Early Postoperative Increase in Intraocular Pressure 69. Tenon''s Cyst Formation and Management 70. Postoperative Shallow Anterior Chamber 71. Aqueous Misdirection 72.
Choroidal Effusion and Hemorrhage 73. Late Bleb Leaks and Complications Associated with Modulation of Wound Healing in Glaucoma Surgery 74. Blebitis and Endophthalmitis 75. Late Hypotony 76. Late Failure of Filtering Bleb 77. Cataract Following Trabeculectomy 78. Trabeculectomy-related Corneal complications Section 10 Nonpenetrating Glaucoma Surgery 79. Non-Penetrating Procedures - Principle and Mechanism of Function 80.
Deep Sclerectomy and Postoperative Management of Nonpenetrating Glaucoma Surgery 81. Results of Nonpenetrating Glaucoma Surgery Section 11 Modulation of Wound Healing 82. Risk factors for excess wound healing 83. Modulation of Wound Healing 84. Biological Drivers of Postoperative Scarring and Future Strategies 85. Bleb Needling and Enhancement Section 12 Management of Co-Existing Cataract and Glaucoma 86. Cataract Surgery in Open Angle Glaucoma 87. The Role of Lens Extraction in Primary Angle Closure Glaucoma 88.
Goniosynechialysis 89. Cataract Surgery in Patients with Functioning Filtering Blebs 90. Combined Phaco and MIGS 91. Combined Sugery: Phacotrabeculectomy 92. Combined cataract extraction and glaucoma drainage implant surgery Section 13 Drainage Devices 93. Preoperative Evaluation of Patients Undergoing Drainage Implant Surgery and Choice of Implant 94. Glaucoma Drainage Implants - Surgical Technique 95. Aqueous Shunts after Retinal Surgery 96.
Intraoperative Complications and Postoperative Complications 97. Glaucoma Implants: Results from Clinical Trials 98. Aqueous Shunts and the Cornea Section 14 Surgery for Congenital Glaucoma 99. Goniotomy and Trabeculotomy 100. Further Surgical Options in Children Section 15 Procedures that Target the Ciliary Body 101. Cyclodestructive Techniques 102. Endophotocoagulation 103. Complications of Cyclodestructive Procedures Section 16 MIGS 104.
Canal Based Procedures 105. Canal based Devices 106. Suprachoroidal Space Based Procedures 107. Subconjunctival Based MIGS Procedures Section 17 New Developments in Glaucoma 108. Neuroprotection, Neuroenhancement, and Neuroregeneration 109. RGC replacement 110. Big Data and Glaucoma 111. Lifestyle Changes in Glaucoma 112.
Meditation and Alternative Therapies for Glaucoma 113. Smartphone and Virtual Reality Devices in Glaucoma screening and detection 114. Telemedicine and Glaucoma 115. AI and Glaucoma.